Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Kasycas
    Member
    • Sep 2009
    • 22

    #1

    MIRA output for Illumina mapping giving 100% coverage!

    Hi all,

    I've been using MIRA as I have both Illumina and 454 reads that I wanted to do mapping/assembly as well as semi-hybrid and hybrid assembly. However, when I use MIRA on the Illumina data alone for mapping with

    "mira --project=0800 --job=mapping,genome,normal,solexa --fastq -SB:bft=gbf >&0800_Illumina_log_assembly.txt"

    I get 1 contig of length 4,798,671 which is pretty much 100% coverage of the genome! I've used bwa and bowtie as well which give me a more realistic ~68-69% coverage. Can anyone tell me why/how MIRA is doing this? I've played around with the setting and read the documentation but I'm at a loss!

    Thanks,

    Kasycas
  • maubp
    Peter (Biopython etc)
    • Jul 2009
    • 1544

    #2
    I'd ask on the MIRA mailing list, but Bastien also posts here.

    My guess is different rules/settings for mismatch thresholds, but also MIRA isn't really doing a mapping but a guided assembly (it will extend the reference sequence(s) if it can).
    Last edited by maubp; 09-10-2010, 03:47 AM. Reason: typo

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    67 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    47 views
    0 reactions
    Last Post SEQadmin2  
    Working...